Mucopolysaccharidosis type VI or Maroteaux-Lamy syndrome is an autosomal recessive lysosomal disease caused by biallelic variants in ARSB. Arylsulfatase B deficiency leads to the accumulation of dermatan sulfate and other glycosaminoglycans, causing progressive connective tissue involvement with usual preservation of intellectual development.
Mucopolysaccharidosis type 6
Mucopolysaccharidosis type VI (MPS VI), or Maroteaux-Lamy syndrome, is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the ARSB gene. Arylsulfatase B deficiency prevents the proper degradation of dermatan sulfate and other glycosaminoglycans, which progressively accumulate in connective tissues and cause multisystemic involvement, generally with preserved cognitive development.
The ARSB gene encodes arylsulfatase B, a lysosomal enzyme involved in the degradation of dermatan sulfate and chondroitin 4-sulfate. The loss of enzyme activity results in the intralysosomal accumulation of these compounds and primarily affects the skeleton, joints, heart, cornea, liver, and respiratory tract.
Symptoms
Manifestations depend on residual enzyme activity. Severe forms appear in early childhood with coarse facial features, short stature, multiple dysostoses, joint stiffness, corneal opacity, hepatosplenomegaly, respiratory problems, cardiac valvulopathy, and possible cervical spinal cord compression. Attenuated forms present a slower progression, although they can develop significant osteoarticular and cardiac involvement.
Disease management
Management requires multidisciplinary monitoring. Enzyme replacement therapy with galsulfase may decrease urinary glycosaminoglycan levels and improve some functional and respiratory parameters, although it has limited effects on established structural alterations. Cardiologic, respiratory, ophthalmologic, auditory, and orthopedic monitoring is required.
Genes analyzed
Bibliography
D'Avanzo F, Zanetti A, De Filippis C, et al. Mucopolysaccharidosis Type VI, an Updated Overview of the Disease. Int J Mol Sci. 2021.
Tomanin R, Karageorgos L, Zanetti A, et al. Mucopolysaccharidosis type VI and molecular analysis. Hum Mutat. 2018.
